Related Experiment Video
Updated: Jan 9, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Towards interprofessional medication safety risk management: a qualitative interview study for physicians in primary
Anu Saavalainen1,2, Henna Sirenius3, Carita Linden-Lahti3,4
1Division of Pharmacology and Pharmacotherapy, University of Helsinki, Helsinki, Uusimaa, Finland anu.saavalainen@helsinki.fi.
Objectives:
Investigate interprofessional medication safety risk management from the perspective of physicians in healthcare settings.
Design:
Qualitative, semistructured interview study. Data analysed with an inductive content analysis.
Setting:
Wellbeing Services County in Central Finland.
Participants:
17 physicians working in different healthcare settings or specialties.
Results:
Physicians' overall perception of interprofessional medication safety risk management was generally positive. They considered their own responsibility for medication safety as both comprehensive, encompassing the safety of the entire unit and limited, focused primarily on prescribing the correct medication. Organisational barriers to participating in medication safety promotion comprised insufficient healthcare resources and unclear distribution of tasks and responsibilities. Personal barriers included prioritisation of clinical work, considering medication safety as an administrative task and experiencing the process to be slow and complex. Strong leadership, increased visibility of medication safety, framing the topic positively, targeted education and fostering physicians' intrinsic motivation were identified as means to increase physicians' participation in medication safety risk management.
Conclusions:
This study emphasises the importance of integrating physicians into interprofessional, systems-based medication safety risk management as a core element of high-quality care. Despite recognising their broad role, physicians face barriers such as organisational constraints and limited identification with medication safety advocacy. Addressing these challenges requires enhancing their understanding of the medication management and use process and fostering shared responsibility through time allocation and interprofessional leadership structures.
More Related Videos
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Dosing: Geriatric Patients
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Methods of Documentation II: POMR
Dosage Regimen: Individualization
Bioavailability Study Design: Healthy Subjects Versus Patients